HOME › DRUGS › RILONACEPT
ACTIVE SUBSTANCE / INN

RILONACEPT

Brand name(s): Rilonacept FGK Representative Service GmbH, ARCALYST, Rilonacept Regeneron (previously Arcalyst)
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
WITHDRAWN
Pericarditis
Cryopyrin-Associated Periodic Syndromes
ACTIVE SUBSTANCE
Rilonacept
REGULATORS
FDA · EMA
SPONSORS / MAH
Regeneron UK Limited, Rilonacept FGK Representative Service GmbH, KINIKSA PHARMACEUTICALS (UK), LTD.
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ARCALYSTBLA125249KINIKSA PHARMACEUTICALS (UK), LTD.Prescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Rilonacept FGK Representative Service GmbHRilonacept FGK Representative Service GmbHApplication withdrawnPericarditis
Rilonacept Regeneron (previously Arcalyst)Regeneron UK LimitedWithdrawn23/10/2009Cryopyrin-Associated Periodic Syndromes

FULL INTELLIGENCE ON RILONACEPT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →